Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SoTiClin: Adjunctive Clindamycin for S. aureus SSTI
NCT05899140Phase 4Recruiting
- Start
- Mar 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clindamycin in skin and soft tissue infection (SSTI). Started Mar 2024; status: recruiting.
02
Drugs
clindamycin
03
Conditions
skin and soft tissue infection (SSTI)
Beyond the preview
Go deeper on NCT05899140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05899140.